Detalhe da pesquisa
1.
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
Blood
; 138(25): 2696-2701, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343258
2.
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.
Blood
; 125(22): 3455-65, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795919
3.
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model.
Blood
; 121(17): 3447-58, 2013 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435463
4.
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice.
Blood
; 116(19): 3907-22, 2010 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20634376
5.
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations.
Biomolecules
; 12(7)2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35883460
6.
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Leukemia
; 36(10): 2351-2367, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008542
7.
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells.
Cancers (Basel)
; 13(3)2021 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33525388
8.
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Leukemia
; 35(9): 2552-2562, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33654209
9.
Mutant NPM1 Maintains the Leukemic State through HOX Expression.
Cancer Cell
; 34(3): 499-512.e9, 2018 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30205049
10.
Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.
Cancer Lett
; 246(1-2): 274-81, 2007 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16650526
11.
Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Blood Rev
; 25(6): 247-54, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21724308